Clinical Implementation of Novel Kidney Injury Biomarkers for Diagnosis Assessment; the NGAL in a Real-life AKI Setting
Jean-Maxime Côté*, Roxanne Authier, Marie-Claire Bélanger
Acute kidney injury (AKI) is a complex syndrome. Novel kidney injury biomarkers have been shown to improve prognostic and diagnostic assessment, but their use has been mostly limited to research settings.
Отказ от ответственности: Этот реферат был переведен с помощью инструментов искусственного интеллекта и еще не прошел проверку или верификацию
